Labeling revisions take aim against medication errors

The U.S. Pharmacopeia proposes revisions to ferrules and cap overseal labeling.

Hp 19103 I Stock Pharmacopeia
In an effort to help prevent medication errors, reports PharmTech.com, the U.S. Pharmacopeia posted a proposed revised standard "for what should and should not appear on the ferrules and cap overseals of medication drugs."

USP's Web site says, "The proposals will appear as an 'In-Process Revision' proposal in Pharmacopeial Forum 36(1) (January - February 2010) for a 90-day public comment period. Comments on the proposed revision will be accepted through April 15, 2010, and should be directed to [email protected]."

According to the U.S. FDA's Web site, "medication errors cause at least one death every day and injure approximately 1.3 million people annually in the United States." The site says errors can occur anywhere within the distribution chain, including repackaging, dispensing, and labeling. The agency offers several resources to help report and address medication errors.
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report